Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
Identifieur interne :
003501 ( PascalFrancis/Curation );
précédent :
003500;
suivant :
003502
Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
Auteurs : F. Tison [
France] ;
L. Wiart [
France] ;
M. Guatterie [
France] ;
N. Fouillet [
France] ;
V. Lozano [
France] ;
P. Henry [
France] ;
M. Barat [
France]
Source :
-
Movement disorders [ 0885-3185 ] ; 1996.
RBID : Pascal:97-0015764
Descripteurs français
English descriptors
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 11 |
|---|
| A06 | | | | @2 6 |
|---|
| A08 | 01 | 1 | ENG | @1 Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease |
|---|
| A11 | 01 | 1 | | @1 TISON (F.) |
|---|
| A11 | 02 | 1 | | @1 WIART (L.) |
|---|
| A11 | 03 | 1 | | @1 GUATTERIE (M.) |
|---|
| A11 | 04 | 1 | | @1 FOUILLET (N.) |
|---|
| A11 | 05 | 1 | | @1 LOZANO (V.) |
|---|
| A11 | 06 | 1 | | @1 HENRY (P.) |
|---|
| A11 | 07 | 1 | | @1 BARAT (M.) |
|---|
| A14 | 01 | | | @1 Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux @3 FRA @Z 1 aut. @Z 4 aut. @Z 6 aut. |
|---|
| A14 | 02 | | | @1 Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux @3 FRA @Z 2 aut. @Z 3 aut. @Z 5 aut. @Z 7 aut. |
|---|
| A20 | | | | @1 729-732 |
|---|
| A21 | | | | @1 1996 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000066890620190 |
|---|
| A44 | | | | @0 0000 @1 © 1997 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 15 ref. |
|---|
| A47 | 01 | 1 | | @0 97-0015764 |
|---|
| A60 | | | | @1 P @3 CC |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B02B09A |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Dysphagie @5 04 |
|---|
| C03 | 02 | X | ENG | @0 Dysphagia @5 04 |
|---|
| C03 | 02 | X | SPA | @0 Disfagia @5 04 |
|---|
| C03 | 03 | X | FRE | @0 Apomorphine @2 NK @2 FR @5 07 |
|---|
| C03 | 04 | X | FRE | @0 Emétique @5 08 |
|---|
| C03 | 04 | X | ENG | @0 Emetic @5 08 |
|---|
| C03 | 04 | X | SPA | @0 Emético @5 08 |
|---|
| C03 | 05 | X | FRE | @0 Agoniste @5 16 |
|---|
| C03 | 05 | X | ENG | @0 Agonist @5 16 |
|---|
| C03 | 05 | X | SPA | @0 Agonista @5 16 |
|---|
| C03 | 06 | X | FRE | @0 Traitement @5 17 |
|---|
| C03 | 06 | X | ENG | @0 Treatment @5 17 |
|---|
| C03 | 06 | X | GER | @0 Aufbereiten @5 17 |
|---|
| C03 | 06 | X | SPA | @0 Tratamiento @5 17 |
|---|
| C03 | 07 | X | FRE | @0 Homme @5 20 |
|---|
| C03 | 07 | X | ENG | @0 Human @5 20 |
|---|
| C03 | 07 | X | SPA | @0 Hombre @5 20 |
|---|
| C03 | 08 | X | FRE | @0 Récepteur dopaminergique @5 23 |
|---|
| C03 | 08 | X | ENG | @0 Dopamine receptor @5 23 |
|---|
| C03 | 08 | X | SPA | @0 Receptor dopaminérgico @5 23 |
|---|
| C03 | 09 | X | FRE | @0 Chimiothérapie @5 24 |
|---|
| C03 | 09 | X | ENG | @0 Chemotherapy @5 24 |
|---|
| C03 | 09 | X | SPA | @0 Quimioterapia @5 24 |
|---|
| C07 | 01 | X | FRE | @0 Système nerveux pathologie @5 37 |
|---|
| C07 | 01 | X | ENG | @0 Nervous system diseases @5 37 |
|---|
| C07 | 01 | X | SPA | @0 Sistema nervioso patología @5 37 |
|---|
| C07 | 02 | X | FRE | @0 Système nerveux central pathologie @5 38 |
|---|
| C07 | 02 | X | ENG | @0 Central nervous system disease @5 38 |
|---|
| C07 | 02 | X | SPA | @0 Sistema nervosio central patología @5 38 |
|---|
| C07 | 03 | X | FRE | @0 Encéphale pathologie @5 39 |
|---|
| C07 | 03 | X | ENG | @0 Cerebral disorder @5 39 |
|---|
| C07 | 03 | X | SPA | @0 Encéfalo patología @5 39 |
|---|
| C07 | 04 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 04 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
|---|
| C07 | 04 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
|---|
| C07 | 05 | X | FRE | @0 Maladie dégénérative @5 41 |
|---|
| C07 | 05 | X | ENG | @0 Degenerative disease @5 41 |
|---|
| C07 | 05 | X | SPA | @0 Enfermedad degenerativa @5 41 |
|---|
| C07 | 06 | X | FRE | @0 Appareil digestif pathologie @5 45 |
|---|
| C07 | 06 | X | ENG | @0 Digestive diseases @5 45 |
|---|
| C07 | 06 | X | SPA | @0 Aparato digestivo patología @5 45 |
|---|
| C07 | 07 | X | FRE | @0 Oesophage pathologie @5 46 |
|---|
| C07 | 07 | X | ENG | @0 Esophageal disease @5 46 |
|---|
| C07 | 07 | X | SPA | @0 Esófago patología @5 46 |
|---|
| N21 | | | | @1 006 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003323
Links to Exploration step
Pascal:97-0015764
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Wiart, L" sort="Wiart, L" uniqKey="Wiart L" first="L." last="Wiart">L. Wiart</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Guatterie, M" sort="Guatterie, M" uniqKey="Guatterie M" first="M." last="Guatterie">M. Guatterie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Lozano, V" sort="Lozano, V" uniqKey="Lozano V" first="V." last="Lozano">V. Lozano</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Barat, M" sort="Barat, M" uniqKey="Barat M" first="M." last="Barat">M. Barat</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0015764</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 97-0015764 INIST</idno>
<idno type="RBID">Pascal:97-0015764</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003323</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003501</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Wiart, L" sort="Wiart, L" uniqKey="Wiart L" first="L." last="Wiart">L. Wiart</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Guatterie, M" sort="Guatterie, M" uniqKey="Guatterie M" first="M." last="Guatterie">M. Guatterie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Lozano, V" sort="Lozano, V" uniqKey="Lozano V" first="V." last="Lozano">V. Lozano</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Barat, M" sort="Barat, M" uniqKey="Barat M" first="M." last="Barat">M. Barat</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14><country>France</country>
</affiliation><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1996">1996</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Dysphagia</term>
<term>Emetic</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Dysphagie</term>
<term>Apomorphine</term>
<term>Emétique</term>
<term>Agoniste</term>
<term>Traitement</term>
<term>Homme</term>
<term>Récepteur dopaminergique</term>
<term>Chimiothérapie</term>
</keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease</s1>
</fA08><fA11 i1="01" i2="1"><s1>TISON (F.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>WIART (L.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>GUATTERIE (M.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>FOUILLET (N.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>LOZANO (V.)</s1>
</fA11><fA11 i1="06" i2="1"><s1>HENRY (P.)</s1>
</fA11><fA11 i1="07" i2="1"><s1>BARAT (M.)</s1>
</fA11><fA14 i1="01"><s1>Department de Neurologie, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14><fA14 i1="02"><s1>Service de Rééducation Fonctionnelle Neurologique, Hôpital Pellegrin, CHU de Bordeaux</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14><fA20><s1>729-732</s1>
</fA20><fA21><s1>1996</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000066890620190</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>15 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>97-0015764</s0>
</fA47><fA60><s1>P</s1>
<s3>CC</s3>
</fA60><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02B09A</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Dysphagie</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Dysphagia</s0>
<s5>04</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Disfagia</s0>
<s5>04</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Emétique</s0>
<s5>08</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Emetic</s0>
<s5>08</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Emético</s0>
<s5>08</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>16</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Agonist</s0>
<s5>16</s5>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Agonista</s0>
<s5>16</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03><fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>23</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>23</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>23</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>24</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>24</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>24</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07><fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07><fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07><fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07><fC07 i1="06" i2="X" l="FRE"><s0>Appareil digestif pathologie</s0>
<s5>45</s5>
</fC07><fC07 i1="06" i2="X" l="ENG"><s0>Digestive diseases</s0>
<s5>45</s5>
</fC07><fC07 i1="06" i2="X" l="SPA"><s0>Aparato digestivo patología</s0>
<s5>45</s5>
</fC07><fC07 i1="07" i2="X" l="FRE"><s0>Oesophage pathologie</s0>
<s5>46</s5>
</fC07><fC07 i1="07" i2="X" l="ENG"><s0>Esophageal disease</s0>
<s5>46</s5>
</fC07><fC07 i1="07" i2="X" l="SPA"><s0>Esófago patología</s0>
<s5>46</s5>
</fC07><fN21><s1>006</s1>
</fN21>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003501 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 003501 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:97-0015764
|texte= Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
